Previous Article | Next Article ![]()
J. Virol., Aug 1995, 4649-4655, Vol 69, No. 8
XF Yu, Z Wang, C Beyrer, DD Celentano, C Khamboonruang, E Allen and K Nelson
Primary human immunodeficiency virus type 1 (HIV-1) isolates were obtained
from 22 patients with AIDS from northern Thailand, where HIV-1 is
transmitted primarily through the heterosexual route. Viral sequences were
determined for the 22 patients with AIDS, and all were subtype E HIV-1 on
the basis of sequence analysis of a region from the envelope protein gp120.
Syncytium-inducing (SI) viruses were detected for 16 of 22 patients with
AIDS by using MT-2 cells. Characteristics of amino acid sequences in V3
which have not been reported previously for subtype B SI HIV-1 were
associated with the subtype E HIV-1 SI phenotype. The SI viruses from our
study population contain predominantly a GPGR or GPGH motif at the tip of
the V3 loop, in contrast to the previously described subtype E HIV-1 from
Thailand which contained predominantly GPGQ. All the SI viruses lost a
potential N-linked glycosylation site in V3 which is highly conserved among
previously described subtype E HIV-1 isolates from asymptomatic patients
from Thailand. HIV-1 envelope sequences including V3 from some patients
with AIDS were significantly more divergent than viruses from asymptomatic
patients in Thailand characterized 2 years ago or earlier. These results
suggest that emergence of subtype E SI HIV-1 variants is associated with
the development of AIDS, as it is for subtype B HIV-1. The divergence of
subtype E HIV-1 in patients with AIDS as the disease progresses, and the
divergence of subtype E HIV-1 in the infected population as the epidemic
continues in Thailand, may have important implications for vaccine
development.
Copyright © 1995, American Society for Microbiology
Phenotypic and genotypic characteristics of human immunodeficiency virus type 1 from patients with AIDS in northern Thailand
Department of Molecular Microbiology and Immunology, Johns Hopkins University School of Hygiene and Public Health, Baltimore, Maryland 21205, USA.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|